← All companies
RAJA
TFA Therapeutics, Inc.
—
—
Key statistics
from XBRL data in SEC filingsMarket cap
—
Revenue (TTM)
$1.25M
Net income (TTM)
-$155K
EPS (TTM)
$0.00
P/E ratio
—
Dividend yield
—
Free cash flow
-$385K
Cash
$3.20K
Total assets
$4.66M
Gross margin
61.1%
52-week range
—
Recent SEC filings
37 most recentAnnual, quarterly & current reports
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Jul 27, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Jun 25, 2026
20-F
ANNUAL REPORT
May 15, 2026
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Nov 26, 2025
20-F/A
AMENDMENT NO. 2 TO FORM 20-F
Sep 23, 2025
20-F
ANNUAL REPORT
Jun 13, 2025
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Dec 6, 2024
20-F/A
AMENDMENT NO. 1 TO FORM 20-F
Oct 28, 2024
20-F
ANNUAL REPORT
Jul 5, 2024
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Mar 19, 2024
6-K
REPORT OF FOREIGN PRIVATE ISSUER
Nov 13, 2023
6-K
CURRENT REPORT
Sep 28, 2023
20-F
ANNUAL REPORT
May 15, 2023
Other filings
NT 20-F
NOTIFICATION OF LATE FILING
Apr 30, 2026
NT 20-F
NOTIFICATION OF LATE FILING
Apr 30, 2025
UPLOAD
Nov 8, 2024
CORRESP
Oct 28, 2024
UPLOAD
Sep 4, 2024
NT 20-F
NOTIFICATION OF LATE FILING
Apr 30, 2024
NT 20-F
EXTENSION FORM
Apr 28, 2023
424B4
PROSPECTUS
Mar 30, 2023
EFFECT
Item F-1; Item 2023-03-29; Item 16:30:00
Mar 29, 2023
CORRESP
Mar 27, 2023
CORRESP
Mar 20, 2023
F-1/A
REGISTRATION STATEMENT
Mar 20, 2023
UPLOAD
Mar 17, 2023
F-1/A
REGISTRATION STATEMENT
Mar 6, 2023
CORRESP
Jan 20, 2023
F-1
REGISTRATION STATEMENT
Jan 20, 2023
UPLOAD
Dec 21, 2022
DRSLTR
Dec 8, 2022
DRS/A
Dec 8, 2022
UPLOAD
Oct 19, 2022
DRSLTR
Sep 20, 2022
DRS/A
Sep 20, 2022
UPLOAD
Jan 11, 2022
DRS
Dec 6, 2021